Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $10.32M in the quarter ending September 30, 2024, with 46.90% growth. This brings the company's revenue in the last twelve months to $34.68M, up 5.64% year-over-year. In the year 2023, Eton Pharmaceuticals had annual revenue of $31.64M with 48.90% growth.

• Revenue (ttm): $34.68M
• Revenue Growth: +5.64%
• P/S Ratio: 10.79
• Revenue / Employee: $1,155,900
• Employees: 30
• Market Cap: 374.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	31.64M	10.39M	48.90%
Dec 31, 2022	21.25M	-581.00K	-2.66%
Dec 31, 2021	21.83M	21.79M	55,879.49%
Dec 31, 2020	39.00K	-920.00K	-95.93%
Dec 31, 2019	959.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.